ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00002079
Brief Title: Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

First Submitted : November 2, 1999
First Submitted that Met QC Criteria : August 30, 2001
First Posted : August 31, 2001 (Estimate)

Last Update Submitted that Met QC Criteria : June 23, 2005
Last Update Posted : June 24, 2005 (Estimate)